Company intelligence
Glaukos Corporation
Pioneering new treatments for chronic eye diseases
Medical Equipment Manufacturing
Aliso Viejo, US
1,150 employees
Founded 1998
2 public signals
About Glaukos Corporation
At Glaukos, our focus is to develop and lead the global ophthalmic market with novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases—therapies that advance the existing standard of care and enrich the lives and treatment alternatives for patients worldwide.
Verified activity
Signals from Glaukos Corporation
2 published signals
Presence & Recognition
Glaukos Corporation will be attending the ESCRS2026 event in London.
Reported by Glaukos Corporation
Partnerships
Glaukos Corporation announced that Select Eye Care for its partnership and recent acquisition of the O2n™ system to perform FDA-approved Epioxa™ cross-linking treatment.
Reported by Chris Dalton